Literature DB >> 14670847

Smooth muscle--specific expression of CYP4A1 induces endothelial sprouting in renal arterial microvessels.

Miao Jiang1, Alexandre Mezentsev, Rowena Kemp, Kihwan Byun, John R Falck, Joseph M Miano, Alberto Nasjletti, Nader G Abraham, Michal Laniado-Schwartzman.   

Abstract

Cytochrome P450 (CYP) 4A1 has been characterized as the most efficient arachidonic acid omega-hydroxylase catalyzing the formation of 20-hydroxyeicosatetraenoic acid (20-HETE), a potent constrictor of the renal and cerebral microcirculation and a mitogen for smooth muscle cells. We constructed adenoviruses expressing the CYP4A1 cDNA or LacZ under the control of the smooth muscle cell-specific promoter SM22alpha (Ad-SM22-4A1 and Ad-SM22-nLacZ, respectively). Beta-galactosidase expression was detected in Ad-SM22-nLacZ-transduced vascular smooth muscle A7r5 and PAC1 cells, but not in Ad-SM22-nLacZ-transduced 3T3 fibroblasts or vascular endothelial cells. Likewise, CYP4A1 mRNA and protein were detected in Ad-SM22-4A1-transduced A7r5 and PAC1 cells. Ad-SM22-4A1-transduced A7r5 cells metabolized lauric acid to 12-hydroxy-lauric acid at a rate 5 times greater than that of cells transduced with Ad-SM22-nLacZ (4.79+/-1.77 versus 0.97+/-0.57 nmol 12-hydroxy lauric acid/10(6) cells per h). Smooth muscle-specific LacZ expression was also detected in microdissected renal interlobar arteries transduced with Ad-SM22-nLacZ. Arteries transduced with Ad-SM22-4A1 produced higher levels of 20-HETE (4.04+/-0.29 and 13.43+/-2.84 ng/mg protein in Ad-SM22-nLacZ-transduced and Ad-SM22-4A1-transduced arteries, respectively) and demonstrated a marked angiogenic activity measured as the total length of sprouting neovessels (12.63+/-3.66 mm in Ad-SM22-4A1-transduced vessels versus 1.79+/-0.89 mm in Ad-SM22-nLacZ-transduced vessels). This angiogenic activity represented endothelial cell sprouting and was fully blocked by treatment with HET0016, a selective inhibitor of CYP4A-catalyzed reactions. The inhibitory effect of HET0016 was reversed by addition of a 20-HETE agonist. We conclude that Ad-SM22-4A1 drives a smooth muscle-specific functional expression of CYP4A1 and demonstrates increased angiogenesis, presumably via increased production of 20-HETE.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14670847     DOI: 10.1161/01.RES.0000111523.12842.FC

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  26 in total

1.  Induction of angiotensin-converting enzyme and activation of the renin-angiotensin system contribute to 20-hydroxyeicosatetraenoic acid-mediated endothelial dysfunction.

Authors:  Jennifer Cheng; Victor Garcia; Yan Ding; Cheng-Chia Wu; Krutanjali Thakar; John R Falck; Errabelli Ramu; Michal Laniado Schwartzman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-06-21       Impact factor: 8.311

Review 2.  EET signaling in cancer.

Authors:  Dipak Panigrahy; Emily R Greene; Ambra Pozzi; Dao Wen Wang; Darryl C Zeldin
Journal:  Cancer Metastasis Rev       Date:  2011-12       Impact factor: 9.264

3.  P450 in the angiogenesis affair: the unusual suspect.

Authors:  Alexander V Ljubimov; Maria B Grant
Journal:  Am J Pathol       Date:  2005-02       Impact factor: 4.307

4.  Contribution of 20-HETE to augmented myogenic constriction in coronary arteries of endothelial NO synthase knockout mice.

Authors:  An Huang; Dong Sun; Changdong Yan; John R Falck; Gabor Kaley
Journal:  Hypertension       Date:  2005-07-25       Impact factor: 10.190

5.  Disrupting calcium channel expression to lower blood pressure: new targeting of a well-known channel.

Authors:  Swapnil Sonkusare; Mony Fraer; James D Marsh; Nancy J Rusch
Journal:  Mol Interv       Date:  2006-12

6.  Intra- and extrarenal arteries exhibit different profiles of contractile responses in high glucose conditions.

Authors:  K Nobe; Y Nezu; N Tsumita; T Hashimoto; K Honda
Journal:  Br J Pharmacol       Date:  2008-09-22       Impact factor: 8.739

7.  20-HETE regulates the angiogenic functions of human endothelial progenitor cells and contributes to angiogenesis in vivo.

Authors:  Li Chen; Rachel Ackerman; Mohamed Saleh; Katherine H Gotlinger; Michael Kessler; Lawrence G Mendelowitz; John R Falck; Ali S Arbab; A Guillermo Scicli; Michal L Schwartzman; Jing Yang; Austin M Guo
Journal:  J Pharmacol Exp Ther       Date:  2014-01-08       Impact factor: 4.030

8.  Elevated 20-HETE in metabolic syndrome regulates arterial stiffness and systolic hypertension via MMP12 activation.

Authors:  Amanda Soler; Ian Hunter; Gregory Joseph; Rebecca Hutcheson; Brenda Hutcheson; Jenny Yang; Frank Fan Zhang; Sachindra Raj Joshi; Chastity Bradford; Katherine H Gotlinger; Rachana Maniyar; John R Falck; Spencer Proctor; Michal Laniado Schwartzman; Sachin A Gupte; Petra Rocic
Journal:  J Mol Cell Cardiol       Date:  2018-02-08       Impact factor: 5.000

Review 9.  20-HETE and blood pressure regulation: clinical implications.

Authors:  Cheng-Chia Wu; Tanush Gupta; Victor Garcia; Yan Ding; Michal L Schwartzman
Journal:  Cardiol Rev       Date:  2014 Jan-Feb       Impact factor: 2.644

Review 10.  Cytochrome P450-derived eicosanoids: the neglected pathway in cancer.

Authors:  Dipak Panigrahy; Arja Kaipainen; Emily R Greene; Sui Huang
Journal:  Cancer Metastasis Rev       Date:  2010-12       Impact factor: 9.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.